Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lori L Arndt"'
Autor:
Ravindra Ganesh, Caroline G. Wilker, Lori L Arndt, Dennis M. Bierle, Sara N. Hanson, Sidna M. Tulledge-Scheitel, Raymund R. Razonable
Publikováno v:
The Journal of Infectious Diseases
Background Breakthrough coronavirus disease 2019 (COVID-19) may occur in fully vaccinated persons. Methods We assessed the clinical outcomes of breakthrough COVID-19 in fully vaccinated individuals. Results In this cohort of 1395 persons (mean age, 5
Autor:
Nicole C.E. Aloia, Betty Jorgenson, Sarah J. Bell, Molly J. Destro Borgen, Mary A. Gilmer, Jennifer J. Larsen, Damian J. Paulson, Christopher R. Gulden, Larry Lutwick, Daniel C. Whipple, Ravindra Ganesh, Sara N. Hanson, Kevin I. Reid, Brian D. Kennedy, W. Charles Huskins, Tammy A. Jackson, Richard J. Horecki, Wilford L. Ramsey, Muhanad Mohamed, Gokhan Anil, Colleena N. Ness, Edward J. Malone, Kevin L. Epps, Sarah R. Lessard, Sara Ausman, Rachel K. Bishop, Susan M. Flaker, Sidna M. Tulledge-Scheitel, Taunya J. Rau-Kane, Paschalis Vergidis, Brian B Kottke, Laura H. Hopkins, Perry W. Sweeten, Mary K. Klingsporn, Ala S. Dababneh, Alexander Heyliger, Raymund R. Razonable, Caroline G. Wilker, Janki Patel, Donna J. Springer, Ryan R. Johnson, Shelly M. Olson, Ryan J. Anderson, Jill M. Smith, Dennis M. Bierle, Ivana N. Micallef, Carl H. Cramer, Raj Palraj, Darcie E. Moehnke, Margaret T. Peinovich, Jennifer A. Matoush, Amber N. Derr, Erin C. Skold, Laurie A. Spielman, Eric O. Gomez Urena, Karen J. Reinschmidt, Marcie Billings, Leigh L. Speicher, Tracy L. Culbertson, Lori L Arndt, Lex D. Hokanson, Maria Teresa Seville, Cory Kudrna, Jenna R. Herzog, David M. Phelan, Bipinchandra Hirisave Krishna, Richard F. Arndt, Robert Orenstein, Jennifer M. Tempelis, Tamara L. Haack
Publikováno v:
Mayo Clinic Proceedings. 96:1250-1261
The administration of spike monoclonal antibody treatment to patients with mild to moderate COVID-19 is very challenging. This article summarizes essential components and processes in establishing an effective spike monoclonal antibody infusion progr
Autor:
John C. O’Horo, Douglas W. Challener, Leigh Speicher, Wendelyn Bosch, Maria Teresa Seville, Dennis M. Bierle, Ravindra Ganesh, Caroline G. Wilker, Richard F. Arndt, Lori L. Arndt, Sidna M. Tulledge-Scheitel, Sara N. Hanson, Raymund R. Razonable
Publikováno v:
Mayo Clinic Proceedings
Anti-spike monoclonal antibodies have proven invaluable in preventing severe outcomes from COVID-19, including hospitalization and death. The rise of the SARS-CoV-2 delta variant begs the question of whether monoclonal antibodies maintain similar eff
Autor:
Molly J. Destro Borgen, Raymund R. Razonable, Andrew D. Badley, Lori L Arndt, Caroline G. Wilker, Dennis M. Bierle, Sara N. Hanson, John C. O’Horo, Arjun Puranik, Richard F. Arndt, Sarah J. Bell, Ravindra Ganesh, AJ Venkatakrishnan, Patrick Lenehan, Sidna M. Tulledge-Scheitel, Jennifer J. Larsen, Alexander Heyliger, Leigh L. Speicher, Robert Orenstein, Colin Pawlowski
Publikováno v:
Journal of Clinical Investigation. 131
BACKGROUNDClinical data to support the use of bamlanivimab for the treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) are needed.METHODS2335 Patients who received single-dose bamlanivimab infusion between November 12, 20
Autor:
Leigh L. Speicher, Jordan K. Rosedahl, Raymund R. Razonable, Lindsey M. Philpot, Lori L Arndt, Caroline G. Wilker, Sidna M. Tulledge-Scheitel, Ravindra Ganesh, Dennis M. Bierle, Richard F. Arndt, Sara N. Hanson, Brian D. Kennedy, Molly J. Destro Borgen, Brian B Kottke, Maria Teresa Seville, Ryan J. Anderson, Priya Ramar, Tracy L. Culbertson, Jennifer J. Larsen
Publikováno v:
The Journal of Infectious Diseases
Background Bamlanivimab and casirivimab-imdevimab are authorized for treatment of mild to moderate coronavirus disease 2019 (COVID-19) in high-risk patients. We compared the outcomes of patients who received these therapies to identify factors associ
Autor:
Molly J. Destro Borgen, Sidna M. Tulledge-Scheitel, Alexander Heyliger, Caroline G. Wilker, Richard F. Arndt, Colin Pawlowski, Andrew D. Badley, Dennis M. Bierle, Sara N. Hanson, Leigh L. Speicher, John C. O’Horo, AJ Venkatakrishnan, Raymund R. Razonable, Lori L Arndt, Robert Orenstein, Jennifer J. Larsen, Patrick Lenehan, Arjun Puranik, Ravindra Ganesh, Sarah J. Bell
Publikováno v:
medRxiv
J Clin Invest
J Clin Invest
BackgroundClinical data to support the use of bamlanivimab for the treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) is needed.Methods2,335 patients who received single-dose bamlanivimab infusion between November 12, 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::055472b3d032597d68db4c680bf1bd17
https://europepmc.org/articles/PMC8168391/
https://europepmc.org/articles/PMC8168391/
Autor:
Maria Teresa Seville, Andrew D. Badley, John C. O’Horo, Michelle C. Hedin, AJ Venkatakrishnan, Caroline G. Wilker, Richard F. Arndt, Patrick Lenehan, Molly J. Destro Borgen, Leigh L. Speicher, Colin Pawlowski, Sidna M. Tulledge-Scheitel, Raymund R. Razonable, Lori L Arndt, Arjun Puranik, Ravindra Ganesh, Sara N. Hanson, Dennis M. Bierle
Publikováno v:
EClinicalMedicine
Background: Real-world clinical data to support the use of casirivimab-imdevimab for the treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) is needed. This study aimed to assess the outcomes of casirivimab-imdevimab trea
Autor:
Razonable RR; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA. Electronic address: Razonable.raymund@mayo.edu., O'Horo JC; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Challener DW; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Arndt L; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Arndt RF; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Clune CG; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Culbertson TL; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Hall ST; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Heyliger A; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Jackson TA; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Kennedy BD; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Larsen J; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Hanson SN; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Sweeten PW; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Tulledge-Scheitel SM; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA., Ganesh R; Mayo Clinic, Rochester, MN, USA; Mayo Clinic Health System, Eau Claire, WI, USA; Mayo Clinic Health System, Franciscan Skemp Healthcare, La Crosse, WI, USA; Mayo Clinic Health System, Mankato, MN, USA; Mayo Clinic Health System, Lake City, MN, USA.
Publikováno v:
Mayo Clinic proceedings [Mayo Clin Proc] 2022 Sep; Vol. 97 (9), pp. 1641-1648. Date of Electronic Publication: 2022 Jun 23.